Nac Akut Al (Acetylcysteine)

• Nac Akut Al is a mucolytic indicated for disorders of the respiratory tract where thick mucus impairs ventilation.
• Acute bronchitis: improves mucus clearance and eases cough.
• Chronic obstructive pulmonary disease (COPD): reduces sputum viscosity to facilitate expectoration.
• Chronic bronchitis: aids in long‑term management by thinning airway secretions.

• Acetylcysteine cleaves disulfide bonds within mucus glycoproteins, disrupting the polymeric network that gives mucus its high viscosity. This depolymerisation lowers mucus thickness, enhances ciliary transport, and promotes expectoration, thereby improving airway patency in respiratory disorders.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Vomiting: occasional emesis after oral intake.
• Unpleasant taste: transient metallic or sulfurous flavor.
• Abdominal discomfort: mild cramps or pain.
• Headache: occasional mild headache.
• Rash: mild skin erythema or itching.

Serious or Rare Side Effects

• Anaphylaxis: rapid onset of breathing difficulty, swelling, or hypotension.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Bronchospasm: worsening wheeze, especially in asthmatic patients.
• Angioedema: swelling of lips, tongue, or face.
• Hepatic dysfunction: elevated liver enzymes.
• Eosinophilic pneumonia: rare inflammatory lung condition.

When prescribing Nac Akut Al, consider the following safety measures.

• Renal impairment: assess kidney function before use.
• Asthma or reactive airway disease: monitor for bronchospasm after administration.
• Gastric ulcer disease: use with caution as nausea may exacerbate symptoms.
• Known hypersensitivity: avoid in patients with prior acetylcysteine allergy.
• Pregnancy and lactation: safety not established; weigh benefits against potential risks.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid)

• Nitroprusside: concurrent use can potentiate hypotensive effects.
• Activated charcoal: may reduce acetylcysteine absorption if given within 2 hours.
• Other mucolytics: additive effects may increase risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely)

• Anticoagulants (e.g., warfarin): possible increase in bleeding tendency.
• ACE inhibitors: may enhance cough frequency.
• Bronchodilators: monitor for additive respiratory effects.
• Antihistamines: may increase sedation in some patients.